Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
Stopped There is sufficient follow-up data to meet the endpoints of the study.
Conditions
Interventions
- DIAGNOSTIC_TEST: Prolaris Testing
Sponsor
Myriad Genetic Laboratories, Inc.